AuntMinnieEurope.com staff writersAINanox signs distribution deal for AI software in ItalyNanox intends to expand the commercial presence of its AI subsidiary, Nanox AI, in Italy.October 21, 2026Nuclear MedicineEANM: Lu-177 edotreotide dose linked to tumor responseObjective response rates climbed from 12% in the lowest dose quartile to 64% in the highest.October 20, 2026Nuclear MedicineEANM: Affibody presents data on HER2 radioligand therapyThe Stockholm, Sweden-based company is highlighting progress across its radiopharmaceutical pipeline.October 19, 2026Nuclear MedicineEANM: Akiram presents first clinical data for CD44v6-targeted therapyThe first-in-human ongoing phase I trial is evaluating Lu-177 AKIR001 in patients with irresectable or metastatic CD44v6-positive solid tumors.October 19, 2026Cardiovascular RadiologyPhilips, UMCG launch EU-funded cardiovascular disease projectPhilipsThe five-year research project will examine strategies for detecting, monitoring, and treating cardiovascular disease.October 15, 2026CTThirona gets CE Mark for AI mucus plug analysis softwareLungQ MP quantifies airway-occluding mucus plugs on chest CT and is certified as a class IIb medical device.October 15, 2026MRIAston University gets funding for pediatric brain tumor MRI researchThe funded research will examine the use of MRI to improve diagnosis and treatment of children with brain tumors.October 13, 2026Molecular ImagingEckert & Ziegler Brazil signs Tb-161 supply deal with TerTheraTerThera will provide non-carrier-added Tb-161 to Eckert & Ziegler Brazil.October 13, 2026UltrasoundMidea completes acquisition of EsaoteEsaoteFinancial terms were not disclosed.October 12, 2026Nuclear MedicineNuclidium images first patient in phase II trial of Cu-61 PSMA tracerThe trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.October 6, 2026Previous PagePage 2 of 962Next PageTop StoriesMolecular ImagingSPECT-guided algorithm can aid in assessing Lu-177 RPT responsesCurrently, there is no standardized approach for deciding when to continue or discontinue Lu-177 PSMA therapy after initial cycles.Nuclear MedicineHybrid imaging experts weigh diagnostic gains against unnecessary scans at CHILI 9.0Digital X-RayWhy conventional x-rays still matter in arthritis imagingNuclear Medicine25th-anniversary PET/CT: USZ's Hüllner on clinical innovation and adoptionCTLung-RADS may speed diagnosis of cystic airspace lung cancer